+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Respiratory Tract Infection Drug"

Upper Respiratory Tract Infection Treatment Market 2025-2029 - Product Thumbnail Image

Upper Respiratory Tract Infection Treatment Market 2025-2029

  • Report
  • March 2025
  • 222 Pages
  • Global
From
Hospital Infection Therapeutics Market 2025-2029 - Product Thumbnail Image

Hospital Infection Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 231 Pages
  • Global
From
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Respiratory Tract Infection Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat infections of the respiratory tract, such as bronchitis, pneumonia, and sinusitis. These drugs are typically antibiotics, antivirals, and anti-inflammatory medications. They are used to reduce symptoms, prevent complications, and reduce the spread of infection. The Respiratory Tract Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. Other companies include AbbVie, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more